SCHEMBL13963590

SCHEMBL13963590

Nc1nc(Nc2ccc([S+](N)[O-])cc2)nn1-c1nc2ccc(Oc3ccccc3)cc2s1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 5/20 0.50
▸ NPC1 O15118 2/20 0.45
▸ MAPT P10636 2/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ TP53 P04637 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ SCN4A P35499 1/20 0.43
▸ SCN9A Q15858 1/20 0.43
▸ AXL P30530 5/20 0.42
▸ TDP1 Q9NUW8 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ FLT3 P36888 2/20 0.37
▸ INSR P06213 3/20 0.36
▸ PIN1 Q13526 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ NFKB2 Q00653 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ RELA Q04206 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2088260 0.86 BACE1 (0.50) BACE1NPC1MAPTRAB9ASMN1; SMN2
SCHEMBL13963588 0.80 BACE1 (0.62) BACE1AXLINSR
SCHEMBL12780837 0.74 BACE1 (0.67) BACE1NPC1MAPTRAB9ASMN1; SMN2
SCHEMBL12779066 0.74 BACE1 (0.63) BACE1NPC1MAPTRAB9ASMN1; SMN2
SCHEMBL12781025 0.73 CA2 (0.51) BACE1NPC1MAPTRAB9ASMN1; SMN2
SCHEMBL12780866 0.72 BACE1 (0.64) BACE1NPC1MAPTRAB9ASMN1; SMN2
SCHEMBL4039312 0.71 FLT3 (0.62) BACE1SMN1; SMN2SCN9AAXLL3MBTL1
SCHEMBL12781140 0.71 BACE1 (0.53) BACE1AXLFLT3IKBKB
SCHEMBL12781085 0.70 BACE1 (0.53) BACE1AXLIKBKB
SCHEMBL12780898 0.70 BACE1 (0.62) BACE1NPC1MAPTRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1562589-B1 DIAMINOTRIAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMA (US) 2009-01-07 — — EP disclosed
Send feedback